Literature DB >> 5809552

Reduction of excessive haematocrit levels in patients with polycythaemia due to hypoxic lung disease by phenylhydrazine hydrochloride and pyrimethamine.

C D Pengelly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5809552      PMCID： PMC2466136          DOI： 10.1136/pgmj.45.527.583

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  5 in total

1.  DAPSONE-INDUCED HAEMOLYSIS.

Authors:  C D PENGELLY
Journal:  Br Med J       Date:  1963-09-14

2.  THE TREATMENT OF PLYCYTHAEMIA A/CHAMBERLAIN DA, MILLARD FJ: THE TREATMENT OF POLYCYTHAEMIA SECONDARY TO HYPOXIC LUNG DISEASE BY CONTINUOUS OXYGEN ADMINISTRATION.

Authors:  D A CHAMBERLAIN; F J MILLARD
Journal:  Q J Med       Date:  1963-10

3.  The use of the isotope 51Cr as a label for red cells.

Authors:  P L MOLLISON; N VEALL
Journal:  Br J Haematol       Date:  1955-01       Impact factor: 6.998

4.  Reduction of haematocrit and red-blood-cell volume in patients with polycythaemia secondary to hypoxic lung disease by dapsone and pyrimethamine.

Authors:  C D Pengelly
Journal:  Lancet       Date:  1966-12-24       Impact factor: 79.321

5.  Effect of phenylhydrazine-induced haemolysis on the urinary excretion of iron after desferrioxamine.

Authors:  R L Cumming; A Goldberg; J Morrow; J A Smith
Journal:  Lancet       Date:  1967-01-14       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.